fda semaglutide shortage resolved 2025 announcement Declares of Novo Nordisk's Wegovy, Ozempic Over Ozempic and Wegovy officially moved
Description
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
GLP-1 medications have changed the game for adults managing obesity and type 2 diabetes.
Enjoy weekly injections and personalized care
Principais benefcios
